we performed a double-blind , placebo-controlled crossover assessment of the efficacy and safety of 3 weeks of intranasal flunisolide spray treatment ( 300 micrograms/day ) in nineteen steroid-dependent chronic asthmatic subjects , who also had nasal polyps or severe rhinitis .
C0060501
spray
C0027430
nasal polyps